Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SC Agrotech's board approved audited standalone financial results for Q4 and FY ended March 31, 2025. Total revenue for the year rose to Rs 247.33 lacs from Rs 166.54 lacs last year, but the growth came entirely from other income (Rs 247.33 lacs) as core revenue from operations stayed flat at Rs 68.11 lacs. Q4 FY25 was weak with revenue from operations at zero, leading to a loss before tax of Rs 75.35 lacs versus a profit of Rs 11.22 lacs in Q4 FY24. Full-year profit before tax slipped to Rs 18.93 lacs from Rs 25.52 lacs, with EPS at Rs 0.32 vs Rs 0.40. The statutory auditors issued an unmodified (clean) opinion. The board also approved reclassification of 10 promoter group entities (including Sheela Maheshwari, Sheel Biotech, Vitro Biotechnologies, and others) to the public category, subject to stock exchange approval.
Mixed picture for shareholders — full-year profit modestly declined and the company swung to a Rs 75 lakh loss in Q4 on zero operating revenue, though auditors gave a clean report. Accumulated losses stand at Rs 331.50 lacs against equity capital of Rs 599.50 lacs, keeping balance sheet weak. Promoter reclassification of 10 entities may dilute promoter holding and alter the shareholding structure pending BSE approval.